Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

Jewel Patch Wearable Cardioverter Defibrillator from Element Science

FDA approves new AI-enabled wearable cardioverter defibrillator

The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.

Cleveland Clinic completes world's first transcontinental remotely assisted HIFU procedure

Cleveland Clinic completes world's first remotely assisted HIFU procedure for prostate cancer

Providers are hopeful their work will further advance the use of such procedures in areas where patients face barriers to accessing cancer care. 

FIRE1 Norm inferior vena cava (IVC) heart failure sensor

Implantable IVC sensor shows early potential to guide heart failure management

The goal is to measure changes in a patient’s IVC area and collapsibility, which can help anticipate when heart failure events might occur. This first-in-human study included data from the first 50 patients to receive the device. 

starfish heart monitor

Starfish-shaped heart monitors use AI to deliver accurate results

Researchers have taken inspiration from starfish to design an AI-powered wearable device that delivers accurate real-time heart monitoring.

Good Pixel Smartwatch Loss of Pulse.

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops

Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.

Kestra Medical Technologies

Wearable heart device company to go public, raise up to $155M

Kestra Medical Technologies, known for its wearable heart monitors and defibrillators, intends to sell 10 million common shares priced somewhere between $14 and $16 per share. 

FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary

These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced. 

Post-stroke follow-up care considerably worse for women than men

Female stroke survivors are less likely to receive a cardiology referral or undergo cardiac monitoring than their male counterparts.